Originally recognized for their direct induced toxicity as a component of the innate immune response, reactive oxygen species (ROS) can profoundly modulate T cell adaptive immune responses. Efficient T cell activation requires: signal 1, consisting of an antigenic peptide-MHC complex binding with the T cell receptor (TCR); signal 2, the interaction of co-stimulatory molecules on T cells and antigen-presenting cells (APC); and signal 3, the generation of innate immune-derived ROS and pro-inflammatory cytokines. This third signal, in particular, has proven essential in generating productive and long-lasting immune responses. Our laboratory previously demonstrated profound antigen-specific hyporesponsiveness in the absence of NADPH-oxidase-derived (NOX) superoxide. To further examine the consequences of ROS deficiency on antigen-specific T cell responses, our laboratory generated the OT-II.Ncf1m1J mouse, possessing superoxide-deficient T cells recognizing the nominal antigen OVA323-339. In this study, we demonstrate that OT-II.Ncf1m1J CD4 T cells displayed a severe reduction in Th1 T cell responses, in addition to blunted IL-12R expression and severely attenuated pro-inflammatory chemokine ligands. Conversely, IFN-γ synthesis and IL-12R synthesis were rescued by the addition of exogenous superoxide via the paramagnetic superoxide donor potassium dioxide (KO2) or superoxide-sufficient DCs. Ultimately, this data highlights the importance of NOX-derived ROS in providing a third signal for adaptive immune maturation by modulating IL-12/IL-12R pathway and the novelty of the OT-II.Ncf1m1J mouse model to determine the role of redox-dependent signaling on effector responses. Thus, targeting ROS represents a promising therapeutic strategy in dampening antigen-specific T cell responses and T cell-mediated autoimmune diseases, such as Type 1 diabetes.